Mobile App

Google Play Apple Store
Quarterly Brief (January-March 2020): A Current Expert Analysis on Important HIV Clinical Decisions
Certified CME/CNE/CPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from January through March of 2020 will discuss recent data from CROI, including clinical implications of low level viremia, special patient populations and new agents.

Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.
 








Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical Center
Faculty
Jose Castillo-Mancilla, MD Jose Castillo-Mancilla, MD
Associate Professor of Medicine
University of Colorado-Anschutz Medical Campus
 

20
Supported by an independent educational grant from ViiV Healthcare

Launch Date: April 23, 2020
Release Date: April 23, 2020
Expiration Date: March 31, 2021

March 31, 2021
Mini Module
6651
QuarterlyBrief_WebBanner_1158.gif
HIV